Drug distribution is the reversible transfer of a drug from the bloodstream into the interstitial and intracellular fluids of the tissues. After a drug enters systemic circulation, it does not stay in the blood vessels. Instead, it moves across capillary walls to reach its site of action. This movement depends heavily on cardiac output, regional blood flow, capillary permeability, and the physical-chemical properties of the drug itself. Highly lipophilic drugs easily cross cell membranes, whereas hydrophilic drugs remain largely confined to extracellular spaces.
Capillary structure dictates how easily drugs leave the circulation. Standard capillaries possess fenestrations or gaps between endothelial cells that allow most water-soluble drugs to pass freely. Conversely, tissues like the central nervous system feature tight junctions with no fenestrations, forming a strict barrier. Drug molecules must be small and unionized to cross these restrictive membranes without dedicated transport proteins.
Once in the blood, many drugs bind reversibly to plasma proteins, primarily albumin for acidic drugs and alpha-1-acid glycoprotein for basic drugs.
Changes in plasma protein levels, such as in severe malnutrition or liver disease, alter the fraction of free drug, potentially causing toxicity without a change in total blood concentration.
Apparent volume of distribution (Vd) is a theoretical pharmacokinetic value that relates the total amount of drug in the body to the concentration of drug in the plasma. It does not correspond to a real anatomical volume.
| Vd Value | Implication | Example |
|---|---|---|
| Low Vd (0.1 L/kg) | Trapped in the plasma compartment | Heparin |
| Intermediate Vd (0.2-0.6 L/kg) | Distributed in extracellular fluid | Gentamicin |
| High Vd (>1 L/kg) | Accumulated heavily in body tissues | Digoxin |
Drugs with an extremely high Vd require larger loading doses because most of the drug leaves the blood and hides away in peripheral tissues.
The rate of drug distribution depends heavily on how much blood supply a given tissue receives. Well-perfused organs—such as the heart, brain, liver, and kidneys—receive drugs almost immediately after administration. Poorly perfused tissues, including adipose tissue, skin, and resting skeletal muscle, take much longer to accumulate therapeutic concentrations. Consequently, initial drug effects are often seen first in high-flow organs, while fat stores act as long-term depots for lipid-soluble agents.
Certain body sites possess specialized protective barriers that restrict foreign substances. The blood-brain barrier (BBB) features endothelial cells with tight junctions and astrocytic feet surrounding capillaries, blocking polar and ionized compounds from entering the central nervous system. Similarly, the placenta acts as a selective barrier, though many lipid-soluble medications, narcotics, and anesthetics still cross freely from maternal circulation to the fetus, posing risks for neonatal respiratory depression.
Clinical realities across Nigeria introduce unique variables into drug distribution patterns. High prevalence rates of malnutrition, chronic infections like malaria, and liver pathologies directly reduce serum albumin levels, altering free drug fractions. Dehydration from gastroenteritis concentrates blood components and shrinks extracellular fluid volumes, changing the apparent volume of distribution. Nurses must account for these nutritional and disease states when administering potent medications.
Understanding distribution helps nurses predict onset times, monitor for adverse effects, and recognize signs of drug toxicity. Drugs with high lipid solubility and large volumes of distribution often have prolonged elimination half-lives because they keep leaching out of fat stores. Nurses must watch for delayed toxicity long after a drug has been discontinued, especially in elderly or frail patients whose body composition includes higher fat-to-water ratios.